Skip to main content
. Author manuscript; available in PMC: 2022 Mar 12.
Published in final edited form as: Science. 2021 Jul 30;373(6554):eabd2893. doi: 10.1126/science.abd2893

Fig. 1. TSLP protects against diet-induced obesity and glucose intolerance.

Fig. 1.

(A) Weights of HFD-fed mice post AAV (Control-AAV or TSLP-AAV). (n=13 mice/group, pooled from 3 independent experiments). F-test. (B to G) Mice fed HFD for 10 weeks prior to AAV and for another 4 weeks thereafter. (B) Weights (n=9 mice/group, pooled from 3 independent experiments). F-test. (C) eWAT masses (n=8–9 mice/group, pooled from 3 independent experiments). t-test. (D) Blood glucose following glucose tolerance test (GTT, n=8–10 mice/HFD group, pooled from 2 independent experiments, with n=5 NC mice shown for reference). F-test. (E) Fasting blood glucose (n=13–15 mice/HFD group, pooled from 3 independent experiments, with n=8 NC mice shown for reference). F-test. (F) HOMA-IR (n=13–14 mice/HFD group, pooled from 3 independent experiments, with n=8 NC mice shown for reference). t-test. (G) Liver TGs (n=12–13 mice/group, pooled from 3 independent experiments). t-test. N.S.=not significant, P≥0.05, *P<0.05, ***P<0.001, ****P<0.0001. Data are mean ± SEM.